112 related articles for article (PubMed ID: 9309136)
1. Role of Merlin/NF2 inactivation in tumor biology.
Petrilli AM; Fernández-Valle C
Oncogene; 2016 Feb; 35(5):537-48. PubMed ID: 25893302
[TBL] [Abstract][Full Text] [Related]
2. An update on the CNS manifestations of neurofibromatosis type 2.
Coy S; Rashid R; Stemmer-Rachamimov A; Santagata S
Acta Neuropathol; 2020 Apr; 139(4):643-665. PubMed ID: 31161239
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis type 2 (NF2): a clinical and molecular review.
Evans DG
Orphanet J Rare Dis; 2009 Jun; 4():16. PubMed ID: 19545378
[TBL] [Abstract][Full Text] [Related]
4. Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.
Ali Khajeh J; Ju JH; Atchiba M; Allaire M; Stanley C; Heller WT; Callaway DJ; Bu Z
J Mol Biol; 2014 Jul; 426(15):2755-68. PubMed ID: 24882693
[TBL] [Abstract][Full Text] [Related]
5. Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2.
Prabhakar S; Beauchamp RL; Cheah PS; Yoshinaga A; Haidar EA; Lule S; Mani G; Maalouf K; Stemmer-Rachamimov A; Jung DH; Welling DB; Giovannini M; Plotkin SR; Maguire CA; Ramesh V; Breakefield XO
Mol Ther Methods Clin Dev; 2022 Sep; 26():169-180. PubMed ID: 35846573
[TBL] [Abstract][Full Text] [Related]
6. Missense variant interaction scanning reveals a critical role of the FERM domain for tumor suppressor protein NF2 conformation and function.
Moesslacher CS; Auernig E; Woodsmith J; Feichtner A; Jany-Luig E; Jehle S; Worseck JM; Heine CL; Stefan E; Stelzl U
Life Sci Alliance; 2023 Aug; 6(8):. PubMed ID: 37280085
[TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study.
Baser ME; Kuramoto L; Joe H; Friedman JM; Wallace AJ; Gillespie JE; Ramsden RT; Evans DG
Am J Hum Genet; 2004 Aug; 75(2):231-9. PubMed ID: 15190457
[TBL] [Abstract][Full Text] [Related]
8. Genome-Wide CRISPR Screen Identifies an NF2-Adherens Junction Mechanistic Dependency for Cardiac Lineage.
Lee CJM; Autio MI; Zheng WH; Song Y; Wang SC; Wong DCP; Xiao J; Zhu Y; Yusoff P; Yei X; Chock WK; Low BC; Sudol M; Foo RS
Circulation; 2024 May; ():. PubMed ID: 38752370
[TBL] [Abstract][Full Text] [Related]
9. Merlin/ERM proteins regulate growth factor-induced macropinocytosis and receptor recycling by organizing the plasma membrane:cytoskeleton interface.
Chiasson-MacKenzie C; Morris ZS; Liu CH; Bradford WB; Koorman T; McClatchey AI
Genes Dev; 2018 Sep; 32(17-18):1201-1214. PubMed ID: 30143526
[TBL] [Abstract][Full Text] [Related]
10. Generation of a zebrafish neurofibromatosis model via inducible knockout of
Rajan ARD; Huang Y; Stundl J; Chu K; Irodi A; Yang Z; Applegate BE; Bronner ME
bioRxiv; 2024 Apr; ():. PubMed ID: 38712289
[TBL] [Abstract][Full Text] [Related]
11. Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein.
Giovannini M; Robanus-Maandag E; Niwa-Kawakita M; van der Valk M; Woodruff JM; Goutebroze L; Mérel P; Berns A; Thomas G
Genes Dev; 1999 Apr; 13(8):978-86. PubMed ID: 10215625
[TBL] [Abstract][Full Text] [Related]
12. Early phase clinical studies of AR-42, a histone deacetylase inhibitor, for neurofibromatosis type 2-associated vestibular schwannomas and meningiomas.
Welling DB; Collier KA; Burns SS; Oblinger JL; Shu E; Miles-Markley BA; Hofmeister CC; Makary MS; Slone HW; Blakeley JO; Mansouri SA; Neff BA; Jackler RK; Mortazavi A; Chang LS
Laryngoscope Investig Otolaryngol; 2021 Oct; 6(5):1008-1019. PubMed ID: 34667843
[TBL] [Abstract][Full Text] [Related]
13. β-hydroxybutyrate does not alter the effects of glucose deprivation on breast cancer cells.
Maldonado R; Talana CA; Song C; Dixon A; Uehara K; Weichhaus M
Oncol Lett; 2021 Jan; 21(1):65. PubMed ID: 33281976
[TBL] [Abstract][Full Text] [Related]
14. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
15. Detection of cellular proteins that interact with the NF2 tumor suppressor gene product.
Takeshima H; Izawa I; Lee PS; Safdar N; Levin VA; Saya H
Oncogene; 1994 Aug; 9(8):2135-44. PubMed ID: 8035998
[TBL] [Abstract][Full Text] [Related]
16. NF2: the wizardry of merlin.
Xiao GH; Chernoff J; Testa JR
Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
Kley N; Whaley J; Seizinger BR
Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
[TBL] [Abstract][Full Text] [Related]
18. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
